Top Markets
Coin of the day
Revive Therapeutics Ltd. Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

RVV
Classement en actions #32620
Revive Therapeutics Ltd., a life sciences firm, specializes in the research and... Revive Therapeutics Ltd., a life sciences firm, specializes in the research and development of treatments for rare disorders and infectious diseases. The company’s pharmaceutical pipeline features a cannabinoid portfolio focused on rare inflammatory ailments. Currently, it is advancing Bucillamine through a Phase 3 clinical study for infectious diseases like influenza and COVID-19. Its psychedelic programs include Psilocybin, undergoing a Phase 1 clinical study for methamphetamine use disorder, and Psilocin, which is being investigated for applications in depression, anxiety, bipolar disorder, bulimia, anorexia nervosa, and other related conditions. Additionally, Revive is exploring cannabidiol for autoimmune hepatitis and for addressing ischemia and reperfusion injury following organ transplantation. The company has forged several significant research collaborations: with PharmaTher Inc. for psilocybin development in cancer treatment, the discovery of other psychedelic compound applications, and a psilocybin microneedle patch; with North Carolina State University to develop a biosynthetic psilocybin based on a natural enzymatic platform; with the University of California, San Francisco, to investigate Bucillamine for severe COVID-19; and with the University of Health Sciences Antigua for clinical research into psychedelics. Established in 2012, Revive Therapeutics Ltd. is headquartered in Toronto, Canada.
Prix de l'action
$0.02201811
Capitalisation boursière
$9.59M
Changement (1 jour)
0.00%
Changement (1 an)
52.14%
Pays
CA
Échange Revive Therapeutics Ltd. (RVV)

Catégorie

Historique du prix de l'action pour Revive Therapeutics Ltd. (RVV)
Prix de clôture le plus élevé : $0.02 le 2026-08-01

Prix de clôture le plus bas : $0.30 le 2013-07-01
Historique du prix de l'action de Revive Therapeutics Ltd. de 2013 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 63.68%
2025 70.41%
2024 -77.79%
2023 -75.71%
2022 -71.59%
2021 -18.22%
2020 1,382.61%
2019 -62.27%
2018 -67.91%
2017 178.40%
2016 -76.10%
2015 -21.59%
2014 51.77%
2013 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$161.79 23.35%
DE
$35.97 20.03%
JP
$220.05 34.49%
CH
$20.77 10.96%
IN